CD19 (Tafasitamab) Recombinant Monoclonal Antibody

• Gene Aliases:

  Antibody deficiency due to defect in CD19 antibody; Antibody deficiency due to defect in CD19; included antibody; AW495831 antibody; B lymphocyte antigen CD19 antibody; B lymphocyte surface antigen B4 antibody; B-lymphocyte antigen CD19 antibody; B-lymphocyte surface antigen B4 antibody; B4 antibody; CD19 antibody; CD19 antigen antibody; CD19 molecule antibody; Cd19 protein antibody; CD19_HUMAN antibody; CVID3 antibody; Differentiation antigen CD19 antibody; Leu 12 antibody; Leu-12 antibody; Leu12 antibody; MGC109570 antibody; MGC12802 antibody; T-cell surface antigen Leu-12 antibody; Tafasitamab

• UniProt:

  P15391

• Antigen Species:

  Human

• Reactivity:

  Human

• Target Antigen:

  Recombinant Human CD19 protein

• Target:

  CD19

• Clonality:

  Monoclonal

• Conjugation:

  Non-conjugated

• Field of Research:

  Immunology; Stem cells

• Purification Method:

  Affinity-chromatography

• Form:

  Liquid

• Storage Conditions:

  Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

• Antibody Type:

  Recombinant Antibody

• Clone ID:

  12G5

• Tested Applications:

  FC; Recommended dilution: FC:1:50-1:200

• Isotype:

  IgG1